Large-scale testing (Phase 3)Study completedNCT04209634
What this trial is testing
Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
Who this might be right for
CD55-deficient Protein-losing EnteropathyCHAPLE
Regeneron Pharmaceuticals 10